Caption Management’s Agios Pharmaceuticals AGIO Stock Holding History

Caption Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,900	Closed	-$732K	–	1503
2025 Q4	$732K	Sell	26,900 -3,100	-10%	-$109K	0.01%	1158
2025 Q3	$1.2M	Sell	30,000 -43,000	-59%	-$1.62M	0.01%	1041
2025 Q2	$2.43M	Buy	73,000 +30,000	+70%	+$909K	0.03%	665
2025 Q1	$1.26M	Buy	43,000 +1,800	+4%	+$59.7K	0.01%	837
2024 Q4	$1.35M	Hold	41,200	–	–	0.01%	830
2024 Q3	$1.83M	Buy	41,200 +13,700	+50%	+$622K	0.03%	593
2024 Q2	$1.19M	Sell	27,500 -20,000	-42%	-$722K	0.02%	622
2024 Q1	$1.39M	Buy	+47,500	New	+$1.27M	0.02%	654
2023 Q4	–	Sell	-60,000	Closed	-$1.49M	–	1306
2023 Q3	$1.49M	Hold	60,000	–	–	0.02%	658
2023 Q2	$1.7M	Sell	60,000 -20,000	-25%	-$498K	0.03%	538
2023 Q1	$1.84M	Buy	80,000 +50,000	+167%	+$1.33M	0.04%	463
2022 Q4	$842K	Hold	30,000	–	–	0.01%	803
2022 Q3	$848K	Buy	+30,000	New	+$805K	0.01%	916
2022 Q2	–	Sell	-77,500	Closed	-$2.26M	–	1399
2022 Q1	$2.26M	Buy	77,500 +50,000	+182%	+$1.53M	0.03%	714
2021 Q4	$905K	Buy	+27,500	New	+$1.11M	0.01%	1079
2021 Q3	–	Sell	-50,000	Closed	-$2.76M	–	1467
2021 Q2	$2.76M	Buy	+50,000	New	+$2.8M	0.04%	564
2021 Q1	–	Sell	-25,000	Closed	-$1.08M	–	1005
2020 Q4	$1.08M	Hold	25,000	–	–	0.02%	590
2020 Q3	$875K	Sell	25,000 -5,000	-17%	-$219K	0.02%	653
2020 Q2	$1.6M	Buy	+30,000	New	+$1.39M	0.05%	425
2020 Q1	–	Sell	-15,000	Closed	-$716K	–	831
2019 Q4	$716K	Sell	15,000 -15,000	-50%	-$567K	0.02%	565
2019 Q3	$971K	Buy	+30,000	New	+$1.24M	0.05%	385

Other funds holding AGIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Caption Management's AGIO Position: Q1 2026 in Review

Caption Management reduced its Agios Pharmaceuticals (AGIO) stake by 87% in Q1 2026, selling an estimated $2.3M and leaving 12,349 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Caption Management first reported a position in AGIO in Q3 2019 and has held it in 18 quarters since. The position peaked at $4.03M in Q1 2021. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

Caption Management held 12,349 shares of Agios Pharmaceuticals worth $418K as of Q1 2026.
Caption Management sold 81,137 Agios Pharmaceuticals shares in Q1 2026, an estimated $2.3M.
Agios Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1244 holding.
Caption Management first reported a position in Agios Pharmaceuticals in Q3 2019 and has held it in 18 quarters since.
Caption Management's Agios Pharmaceuticals position peaked at $4.03M in Q1 2021.
232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.